{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:18:54Z","timestamp":1791688734440,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 CA186107"],"award-info":[{"award-number":["UM1 CA186107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 CA186107"],"award-info":[{"award-number":["UM1 CA186107"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer Investigator Sponsored Research (ISR) grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02444-x","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T17:07:53Z","timestamp":1667322473000},"page":"807-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women"],"prefix":"10.1007","volume":"315","author":[{"given":"Isabelle H.","family":"Moseley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D.","family":"Ragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae H.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Reginato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"2444_CR1","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jaad.2019.06.1300","volume":"83","author":"H Lee","year":"2020","unstructured":"Lee H, Jung SJ, Patel AB, Thompson JM, Qureshi A, Cho E (2020) Racial characteristics of alopecia areata in the United States. J Am Acad Dermatol 83:1064\u20131070","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jocd.12224","volume":"15","author":"MMT Fawzi","year":"2016","unstructured":"Fawzi MMT, Mahmoud SB, Ahmed SF, Shaker OG (2016) Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. J Cosmet Dermatol 15:318\u2013323","journal-title":"J Cosmet Dermatol"},{"key":"2444_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaad.2020.06.047","volume":"85","author":"A Toussi","year":"2021","unstructured":"Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M (2021) Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol 85:162\u2013175","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM et al (2018) Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 78:1\u201312","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1684\/ejd.2013.2042","volume":"23","author":"CN Giordano","year":"2013","unstructured":"Giordano CN, Sinha AA (2013) Cytokine pathways and interactions in alopecia areata. Eur J Dermatol 23:308\u2013318","journal-title":"Eur J Dermatol"},{"key":"2444_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123397","volume":"10","author":"A Wa\u015bkiel-Burnat","year":"2021","unstructured":"Wa\u015bkiel-Burnat A, Osi\u0144ska M, Sali\u0144ska A, Blicharz L, Goldust M, Olszewska M et al (2021) The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications. Cells 10:3397","journal-title":"Cells"},{"issue":"466\u201377","key":"2444_CR7","volume":"80","author":"S Lee","year":"2019","unstructured":"Lee S, Lee H, Lee CH, Lee WS (2019) Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol 80(466\u201377):e16","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89776","volume":"1","author":"M Kennedy Crispin","year":"2016","unstructured":"Kennedy Crispin M, Ko JM, Craiglow BG, Li S, Shankar G, Urban JR et al (2016) Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight 1:e89776","journal-title":"JCI Insight"},{"key":"2444_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jaad.2016.04.029","volume":"75","author":"M Liu","year":"2016","unstructured":"Liu M, Murphy E, Amerson EH (2016) Rethinking screening for thyroid autoimmunity in vitiligo. J Am Acad Dermatol 75:1278\u20131280","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","volume":"65","author":"S-Y Chu","year":"2011","unstructured":"Chu S-Y, Chen Y-J, Tseng W-C, Lin M-W, Chen T-J, Hwang C-Y et al (2011) Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol 65:949\u2013956","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR11","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2105\/AJPH.2016.303315","volume":"106","author":"WQ Li","year":"2016","unstructured":"Li WQ, Cho E, Weinstock MA, Mashfiq H, Qureshi AA (2016) Epidemiological assessments of skin outcomes in the nurses\u2019 health studies. Am J Public Health 106:1677\u20131683","journal-title":"Am J Public Health"},{"key":"2444_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80:27\u201338","journal-title":"Biometrika"},{"key":"2444_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/00949655.2020.1817924","volume":"91","author":"AC Adhikary","year":"2021","unstructured":"Adhikary AC, Shafiqur RM (2021) Firth\u2019s penalized method in Cox proportional hazard framework for developing predictive models for sparse or heavily censored survival data. J Stat Comput Simul 91:445\u2013463","journal-title":"J Stat Comput Simul"},{"key":"2444_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/exd.12209","volume":"22","author":"KJ McElwee","year":"2013","unstructured":"McElwee KJ, Gilhar A, Tobin DJ, Ramot Y, Sundberg JP, Nakamura M et al (2013) What causes alopecia areata? Exp Dermatol 22:609\u2013626","journal-title":"Exp Dermatol"},{"key":"2444_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-020-09115-x","volume":"68","author":"K Kridin","year":"2020","unstructured":"Kridin K, Shalom G, Comaneshter D, Cohen AD (2020) Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study. Immunol Res 68:1\u20136","journal-title":"Immunol Res"},{"key":"2444_CR16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir AM, Thomsen SF (2018) Comorbidities in vitiligo: comprehensive review. Int J Dermatol 57:1157\u20131164","journal-title":"Int J Dermatol"},{"key":"2444_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/ymj.2015.56.3.719","volume":"56","author":"H Lee","year":"2015","unstructured":"Lee H, Lee M-H, Lee DY, Kang HY, Kim KH, Choi GS et al (2015) Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 56:719\u2013725","journal-title":"Yonsei Med J"},{"key":"2444_CR18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"YT Chen","year":"2015","unstructured":"Chen YT, Chen YJ, Hwang CY, Lin MW, Chen TJ, Chen CC et al (2015) Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol 29:1362\u20131369","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2444_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2230.2005.01813.x","volume":"30","author":"JB Liu","year":"2005","unstructured":"Liu JB, Li M, Yang S, Gui JP, Wang HY, Du WH et al (2005) Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327\u2013331","journal-title":"Clin Exp Dermatol"},{"key":"2444_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T (2011) Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int 60:505\u2013508","journal-title":"Allergol Int"},{"key":"2444_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1468-3083.2010.03605.x","volume":"24","author":"BN Akay","year":"2010","unstructured":"Akay BN, Bozkir M, Anadolu Y, Gullu S (2010) Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol 24:1144\u20131150","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2444_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/ced.14507","volume":"46","author":"A Egeberg","year":"2021","unstructured":"Egeberg A, Anderson S, Edson-Heredia E, Burge R (2021) Comorbidities of alopecia areata: a population-based cohort study. Clin Exp Dermatol 46:651\u2013656","journal-title":"Clin Exp Dermatol"},{"key":"2444_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10238-018-0511-8","volume":"18","author":"VKV Gade","year":"2018","unstructured":"Gade VKV, Mony A, Munisamy M, Chandrashekar L, Rajappa M (2018) An investigation of vitamin D status in alopecia areata. Clin Exp Med 18:577\u2013584","journal-title":"Clin Exp Med"},{"key":"2444_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/ijd.14737","volume":"59","author":"A Rossi","year":"2020","unstructured":"Rossi A, Muscianese M, Federico A, Magri F, Caro G, Fortuna MC et al (2020) Associations between alopecia areata and multiple sclerosis: a report of two cases and review of the literature. Int J Dermatol 59:490\u2013493","journal-title":"Int J Dermatol"},{"key":"2444_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/BF03344095","volume":"29","author":"C Alviggi","year":"2006","unstructured":"Alviggi C, Carrieri PB, Pivonello R, Scarano V, Pezzella M, De Placido G et al (2006) Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. J Endocrinol Invest 29:182\u2013189","journal-title":"J Endocrinol Invest"},{"key":"2444_CR26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.jns.2017.08.3007","volume":"381","author":"Y Tada","year":"2017","unstructured":"Tada Y, Hamaguchi T, Ikeda Y, Kazuya T, Yamada M (2017) Multiple sclerosis and alopecia areata. J Neurol Sci 381:1064","journal-title":"J Neurol Sci"},{"key":"2444_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fneur.2017.00569","volume":"8","author":"J Zimmermann","year":"2017","unstructured":"Zimmermann J, Buhl T, M\u00fcller M (2017) Alopecia universalis following alemtuzumab treatment in multiple sclerosis: a barely recognized manifestation of secondary autoimmunity-report of a case and review of the literature. Front Neurol 8:569","journal-title":"Front Neurol"},{"key":"2444_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.msard.2018.12.005","volume":"27","author":"C Alcal\u00e1","year":"2019","unstructured":"Alcal\u00e1 C, Pz\u00e9re-Miralles F, Gasc\u00f3n F, Evole M, Estutia M, Gil-Perot\u00edn S et al (2019) Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: a secondary autoimmune disease. Mult Scler Relat Disord 27:406\u2013408","journal-title":"Mult Scler Relat Disord"},{"key":"2444_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000990","volume":"8","author":"L Rolfes","year":"2021","unstructured":"Rolfes L, Pfeuffer S, Hackert J, Pawlitzki M, Ruck T, Sondermann W et al (2021) Skin reactions in patients with multiple sclerosis receiving cladribine treatment. Neurol Neuroimmunol Neuroinflamm 8:e990","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2444_CR30","doi-asserted-by":"crossref","first-page":"2050313x2091961","DOI":"10.1177\/2050313X20919614","volume":"8","author":"LD Chin","year":"2020","unstructured":"Chin LD, AbuHilal M (2020) Ocrelizumab-induced alopecia areata-A series of five patients from Ontario, Canada: a case report. SAGE Open Med Case Rep. 8:2050313x20919614","journal-title":"SAGE Open Med Case Rep."},{"key":"2444_CR31","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/rheumatology\/keu145","volume":"53","author":"J B\u00e9n\u00e9","year":"2014","unstructured":"B\u00e9n\u00e9 J, Moulis G, Auffret M, Lefevre G, Coquerelle P, Coupe P et al (2014) Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database. Rheumatology 53:1465\u20131469","journal-title":"Rheumatology"},{"key":"2444_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"HH Lee","year":"2019","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E et al (2019) Epidemiology of alopecia areata, ophiasis, totalis and universalis: a systematic review and meta-analysis. J Am Acad Dermatol 82:675\u2013682","journal-title":"J Am Acad Dermatol"},{"key":"2444_CR33","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/1346-8138.14648","volume":"45","author":"TY Han","year":"2018","unstructured":"Han TY, Lee JH, Noh TK, Choi MW, Yun J-S, Lee KH et al (2018) Alopecia areata and overt thyroid diseases: a nationwide population-based study. J Dermatol 45:1411\u20131417","journal-title":"J Dermatol"},{"key":"2444_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00403-020-02109-7","volume":"313","author":"Y-X Dai","year":"2021","unstructured":"Dai Y-X, Tai Y-H, Chang Y-T, Chen T-J, Chen M-H (2021) Bidirectional association between alopecia areata and thyroid diseases: a nationwide population-based cohort study. Arch Dermatol Res 313:339\u2013346","journal-title":"Arch Dermatol Res"},{"key":"2444_CR35","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1007\/s12325-021-01845-0","volume":"38","author":"M Senna","year":"2021","unstructured":"Senna M, Ko J, Tosti A, Edson-Heredia E, Fenske DC, Ellinwood AK et al (2021) Alopecia Areata treatment patterns, healthcare resource utilization, and comorbidities in the US population using insurance claims. Adv Ther 38:4646\u20134658","journal-title":"Adv Ther"},{"key":"2444_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1159\/000512747","volume":"237","author":"J Maghfour","year":"2021","unstructured":"Maghfour J, Olson J, Conic RR, Mesinkovska NA (2021) The association between alopecia and inflammatory bowel disease: a systematic review and meta-analysis. Dermatology 237:658\u2013672","journal-title":"Dermatology"},{"key":"2444_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaad.2016.08.022","volume":"76","author":"M Kim","year":"2017","unstructured":"Kim M, Choi KH, Hwang SW, Lee YB, Park HJ, Bae JM (2017) Inflammatory bowel disease is associated with an increased risk of inflammatory skin diseases: a population-based cross-sectional study. J Am Acad Dermatol 76:40\u201348","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02444-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:04:33Z","timestamp":1681124673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02444-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02444-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the institutional review boards of the Brigham and Women\u2019s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}}]}}